Tags

Type your tag names separated by a space and hit enter

Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective.
Prog Cardiovasc Dis. 2023 Jan-Feb; 76:102-111.PC

Abstract

Despite some indicators of a localized curtailing of cardiovascular disease (CVD) prevalence, CVD remains one of the largest contributors to global morbidity and mortality. While the magnitude and impact of the coronavirus disease 2019 (COVID-19) pandemic have yet to be realized in its entirety, an unquestionable impact on global health and well-being is already clear. At a time when the global state of CVD is perilous, we provide a continental overview of prevalence data and initiatives that have positively influenced CVD outcomes. What is clear is that despite attempts to address the global burden of CVD, there remains a lack of collective thinking and approaches. Moving forward, a coordinated global infrastructure that, if developed with appropriate and relevant key stakeholders, could provide significant and longstanding benefits to public health and yield prominent and consistent policy resulting in impactful change. To achieve global impact, research priorities that address multi-disciplinary social, environmental, and clinical perspectives must be underpinned by unified approaches that maximize public health.

Links

PMC Free PDF

Authors+Show Affiliations

Faghy MA
Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK; Department of Physical Therapy, College of Applied Sciences, University of Illinois at Chicago, Chicago, IL, United States of America; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America. Electronic address: M.Faghy@Derby.ac.uk.
Yates J
Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK.
Hills AP
Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
Jayasinghe S
School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
da Luz Goulart C
Cardiopulmonary Physiotherapy Laboratory, Department of Physiotherapy, Federal University of São Carlos, São Carlos, São Paulo, Brazil.
Arena R
Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK; Department of Physical Therapy, College of Applied Sciences, University of Illinois at Chicago, Chicago, IL, United States of America; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America.
Laddu D
Department of Physical Therapy, College of Applied Sciences, University of Illinois at Chicago, Chicago, IL, United States of America; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America.
Gururaj R
Department of Physiotherapy, Ramaiah Medical College, Bengaluru, India.
Veluswamy SK
Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America; Department of Physiotherapy, Ramaiah Medical College, Bengaluru, India.
Dixit S
Department of Medical Rehabilitation Sciences, King Khalid University, Saudi Arabia.
Ashton REM
Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America.

MeSH

HumansCardiovascular DiseasesCOVID-19PrevalenceDelivery of Health CareInternationality

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

36693488

Citation

Faghy, Mark A., et al. "Cardiovascular Disease Prevention and Management in the COVID-19 Era and Beyond: an International Perspective." Progress in Cardiovascular Diseases, vol. 76, 2023, pp. 102-111.
Faghy MA, Yates J, Hills AP, et al. Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective. Prog Cardiovasc Dis. 2023;76:102-111.
Faghy, M. A., Yates, J., Hills, A. P., Jayasinghe, S., da Luz Goulart, C., Arena, R., Laddu, D., Gururaj, R., Veluswamy, S. K., Dixit, S., & Ashton, R. E. M. (2023). Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective. Progress in Cardiovascular Diseases, 76, 102-111. https://doi.org/10.1016/j.pcad.2023.01.004
Faghy MA, et al. Cardiovascular Disease Prevention and Management in the COVID-19 Era and Beyond: an International Perspective. Prog Cardiovasc Dis. 2023 Jan-Feb;76:102-111. PubMed PMID: 36693488.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective. AU - Faghy,Mark A, AU - Yates,James, AU - Hills,Andrew P, AU - Jayasinghe,Sisitha, AU - da Luz Goulart,Cássia, AU - Arena,Ross, AU - Laddu,Deepika, AU - Gururaj,Rachita, AU - Veluswamy,Sundar Kumar, AU - Dixit,Snehil, AU - Ashton,Ruth E M, Y1 - 2023/01/21/ PY - 2023/01/17/received PY - 2023/01/17/accepted PY - 2023/1/25/pubmed PY - 2023/3/21/medline PY - 2023/1/24/entrez KW - Cardiovascular disease KW - Chronic conditions KW - Health and well-being SP - 102 EP - 111 JF - Progress in cardiovascular diseases JO - Prog Cardiovasc Dis VL - 76 N2 - Despite some indicators of a localized curtailing of cardiovascular disease (CVD) prevalence, CVD remains one of the largest contributors to global morbidity and mortality. While the magnitude and impact of the coronavirus disease 2019 (COVID-19) pandemic have yet to be realized in its entirety, an unquestionable impact on global health and well-being is already clear. At a time when the global state of CVD is perilous, we provide a continental overview of prevalence data and initiatives that have positively influenced CVD outcomes. What is clear is that despite attempts to address the global burden of CVD, there remains a lack of collective thinking and approaches. Moving forward, a coordinated global infrastructure that, if developed with appropriate and relevant key stakeholders, could provide significant and longstanding benefits to public health and yield prominent and consistent policy resulting in impactful change. To achieve global impact, research priorities that address multi-disciplinary social, environmental, and clinical perspectives must be underpinned by unified approaches that maximize public health. SN - 1873-1740 UR - https://www.unboundmedicine.com/medline/citation/36693488/Cardiovascular_disease_prevention_and_management_in_the_COVID_19_era_and_beyond:_An_international_perspective_ DB - PRIME DP - Unbound Medicine ER -